Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60 - PubMed (original) (raw)

Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60

A S Kraft et al. Proc Natl Acad Sci U S A. 1986 Mar.

Abstract

Phorbol esters bind to and activate a calcium phospholipid-dependent protein kinase (C kinase). Some researchers believe that activation of C kinase is necessary for the induction of phorbol ester biologic effects. Our research indicates that bryostatin, a macrocyclic lactone that binds to the phorbol ester receptor in human polymorphonuclear leukocytes, also binds to this receptor in the human promyelocytic leukemia cell line, HL-60. Bryostatin activates partially purified C kinase from HL-60 cells in vitro, and when applied to HL-60 cells in vivo, it decreases measurable cytoplasmic C kinase activity. Unlike the phorbol esters, bryostatin is unable to induce a macrophage-like differentiation of HL-60 cells; however, bryostatin, in a dose-dependent fashion, blocks phorbol ester-induced differentiation of HL-60 cells and, if applied within 48 hr of phorbol esters, halts further differentiation. These results suggest that activation of the C kinase by some agents is not sufficient for induction of HL-60 cell differentiation and imply that some of the biologic effects of phorbol esters may occur through a more complex mechanism than previously thought.

PubMed Disclaimer

Cited by

PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain.
Malik AU, Karapetsas A, Nirujogi RS, Chatterjee D, Phung TK, Wightman M, Gourlay R, Morrice N, Mathea S, Knapp S, Alessi DR. Malik AU, et al. Biochem J. 2022 Sep 30;479(18):1941-1965. doi: 10.1042/BCJ20220308. Biochem J. 2022. PMID: 36040231 Free PMC article.
Structural insights into C1-ligand interactions: Filling the gaps by in silico methods.
Katti S, Igumenova TI. Katti S, et al. Adv Biol Regul. 2021 Jan;79:100784. doi: 10.1016/j.jbior.2020.100784. Epub 2021 Jan 18. Adv Biol Regul. 2021. PMID: 33526356 Free PMC article. Review.
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes.
Barreca M, Spanò V, Montalbano A, Cueto M, Díaz Marrero AR, Deniz I, Erdoğan A, Lukić Bilela L, Moulin C, Taffin-de-Givenchy E, Spriano F, Perale G, Mehiri M, Rotter A, P Thomas O, Barraja P, Gaudêncio SP, Bertoni F. Barreca M, et al. Mar Drugs. 2020 Dec 4;18(12):619. doi: 10.3390/md18120619. Mar Drugs. 2020. PMID: 33291602 Free PMC article. Review.
Equivocal, explicit and emergent actions of PKC isoforms in cancer.
Parker PJ, Brown SJ, Calleja V, Chakravarty P, Cobbaut M, Linch M, Marshall JJT, Martini S, McDonald NQ, Soliman T, Watson L. Parker PJ, et al. Nat Rev Cancer. 2021 Jan;21(1):51-63. doi: 10.1038/s41568-020-00310-4. Epub 2020 Nov 11. Nat Rev Cancer. 2021. PMID: 33177705 Review.
Functional proteomic analysis reveals roles for PKCδ in regulation of cell survival and cell death: Implications for cancer pathogenesis and therapy.
Speidel JT, Affandi T, Jones DNM, Ferrara SE, Reyland ME. Speidel JT, et al. Adv Biol Regul. 2020 Dec;78:100757. doi: 10.1016/j.jbior.2020.100757. Epub 2020 Sep 28. Adv Biol Regul. 2020. PMID: 33045516 Free PMC article.

References

1. J Biol Chem. 1982 Jul 10;257(13):7847-51 - PubMed
1. Blood. 1981 Aug;58(2):237-43 - PubMed
1. J Biol Chem. 1982 Nov 25;257(22):13193-6 - PubMed
1. Proc Natl Acad Sci U S A. 1983 Jan;80(1):36-40 - PubMed
1. Nature. 1983 Feb 17-23;301(5901):621-3 - PubMed

Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60 - PubMed (original) (raw)